CompletedPhase 2

Baked Milk Oral Immunotherapy for Cow's Milk Allergy

United States41 participantsStarted 2018-03-15

Plain-language summary

The purpose of this study is to determine whether baked milk oral immunotherapy is safe in the treatment of cow's milk allergy.

Age range3 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. Forced expiratory volume in 1 second (FEV1) \<80% of predicted
✕. Inhaled corticosteroid dosing dosing of \>500 mcg daily of fluticasone (or equivalent inhaled corticosteroids based on NHLBI dosing chart) or
✕. ≥ 1 hospitalization in the past year for asthma or
✕. \> 1 emergency department visit in the past 6 months for asthma

Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0

Timeframe: 1 year

NCT IDNCT03462030

SponsorJohns Hopkins University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-01-25

Results submitted2021-10-06